Intel raises capital expenditure, benefiting ASML and ASMI
AI summary card
Intel raises capital expenditure, benefiting ASML and ASMI
Morgan Stanley believes that Intel's increase of its 2026 capital expenditure to more than $20 billion, with incremental spending concentrated on advanced process equipment, will make ASML and ASMI key beneficiaries.
- Intel expects equipment spending to grow 40% year over year in 2026 and said 2027 capital expenditure will be significantly higher than in 2026.
- The report believes both ASML and ASMI may benefit, as Intel has historically contributed more than 10% of equipment revenue for both companies.
- For ASML, the serviceable market for Intel 14A is estimated to be about 40% larger than that of the Intel 3 node, supporting orders and pricing.
- Morgan Stanley has not yet raised its ASML shipment assumptions, but believes higher demand strengthens ASML's pricing power and the logic for near-term margin improvement.
Report interpretation
Overview
This report discusses the potential impact on European semiconductor equipment companies ASML and ASMI after Intel raised its capital expenditure plan on its earnings call. Intel said that, driven by strong demand, its 2026 capital expenditure outlook has been increased to more than $20 billion, a significant upward revision from market expectations at the start of the year; its incremental capital expenditure is mainly directed toward equipment, especially front-end tools related to Intel 3, 18A, 18A-P, and 14A. Morgan Stanley believes ASML and ASMI will be key beneficiaries of this investment cycle.
Core views
The core view is that Intel's accelerated investment pace in advanced nodes will increase demand for key semiconductor equipment and create upside pressure on ASML's and ASMI's revenue and orders. The report points out that Intel has long been an important customer of both ASML and ASMI, estimated to contribute more than 10% of equipment revenue to each company. Among them, ASML benefits from the advancement of the 18A and 14A nodes, while ASMI benefits from demand for advanced front-end tools; the serviceable market for the Intel 14A node is estimated to be significantly larger than that of the Intel 3 node.
Analysis framework
The report uses an event-driven analysis approach: it first reviews changes in capital expenditure, cleanroom capacity, equipment procurement, and advanced node planning from Intel's earnings call, and then maps these to customer revenue exposure, node equipment intensity, EUV shipments, and pricing power for European semiconductor equipment companies. The focus of the analysis is not to provide a new valuation model, but to assess the directional impact of changes in Intel's capital expenditure on ASML's and ASMI's orders, revenue expectations, and margin trends.
Methodology notes
The impact of customer capital expenditure increases on equipment suppliers' revenue expectations
When key customers concentrate incremental capital expenditure on production tools and advanced process nodes, equipment suppliers' orders, shipments, and pricing power are usually supported.
Customer share and serviceable market size for advanced nodes
The report assesses the degree of benefit based on Intel's historical revenue share in ASML and ASMI, as well as the higher equipment demand intensity of 14A relative to the Intel 3 node.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- ASML HOLDING NV / ASML.AS / ASML.USA key equipment supplier benefiting from Intel's advanced-node capital expenditure
- Strengths
- Intel has historically been an important customer for ASML; progress in the 18A and 14A nodes increases demand for EUV and related front-end equipment; stronger demand supports price increases and margin improvement.
- Weaknesses
- The report says ASML may face near-term delivery constraints, so shipment estimates have not yet been raised.
- Comparison
- ASML's serviceable market for 14A relative to the Intel 3 node is estimated to be about 40% larger, similar to the increase in equipment intensity brought by more advanced nodes.
- Risks
- There is uncertainty around Intel's investment execution pace, ASML's delivery capability, EUV tool order conversion, pricing realization, and progress in advanced-node mass production.
- ASM International NV / ASMI.ASA potential beneficiary of Intel's front-end tool investment
- Strengths
- Intel has historically contributed more than 10% of ASMI's equipment revenue; increased investment in 18A- and 14A-related front-end tools supports its order and revenue expectations.
- Weaknesses
- The report provides fewer quantitative details for ASMI than for ASML, and the magnitude of benefit will need to be validated by subsequent orders and the pace of customer investment.
- Comparison
- Compared with ASML, ASMI's benefit thesis is more concentrated in front-end tools and advanced-node equipment demand, rather than EUV shipments.
- Risks
- Customer concentration, Intel's node investment pace, equipment procurement timing, and yield progress in advanced processes may affect revenue realization.
- INTEL CORP / INTC.USThe trigger for the capital expenditure increase and a key customer
- Strengths
- Strong demand has driven the capital expenditure increase, and prior investment in cleanrooms and space capacity allows more of the incremental spending to be directed toward equipment.
- Weaknesses
- A significant increase in capital expenditure may raise pressure on cash flow and investment returns.
- Comparison
- Intel's current investment focus is on the Intel 3, 18A, 18A-P, and 14A nodes, reflecting its push to catch up in advanced processes and prepare for mass production.
- Risks
- Mass production of advanced nodes, risk reduction, the ramp to high-volume manufacturing in 2028, capital expenditure returns, and changes in market demand are all key uncertainties.
Key data
- Intel 2026 capital expenditure outlook超过$20bnIntel said on its earnings call that its 2026 capital expenditure outlook has been significantly raised versus expectations at the start of the year.
- Intel 2026 equipment spending growth+40% YoYEquipment investment is focused on front-end tools for Intel 3, 18A, and 18A-P nodes.
- Morgan Stanley's forecast for Intel 2027 capital expenditure$30bnIntel guided that 2027 capital expenditure will be significantly higher than in 2026.
- Estimated revenue contribution from Intel to ASML历史上超过10%;2022年估计约18%;近期MSe约11%The report says Intel has consistently been one of ASML's important customers.
- ASML low-NA EUV shipment assumption to IntelFY26为1台,FY27为6台The report says it is not adjusting estimates for now, but believes Intel demand this year could reach 2 to 4 low-NA EUV tools.
- ASML serviceable market size for Intel 14A relative to Intel 3约高40%The report compares this to the difference between TSMC's 3nm and A14 nodes.
- ASML current price€1,579.20The table lists this as ASML.AS historical price as of 2026-07-23, without stock split adjustment.
- ASMI current price€873.60The table lists this as ASMI.AS historical price as of 2026-07-23, without stock split adjustment.
Impact & implications
The investment implication is positive: Intel's capital expenditure increase not only raises equipment demand in 2026, but also suggests continued advanced-node investment in 2027. For ASML, Intel's earlier push on 14A and more aggressive locking in of tool orders help validate EUV demand, support pricing, and improve near-term margin expectations; for ASMI, Intel's investment in front-end tools and advanced nodes will strengthen its revenue opportunity as an equipment supplier. The report also notes that ASML's near-term delivery capacity may be a constraint, so Morgan Stanley has not changed its shipment forecast for now.
Risks
- ASML may face near-term delivery capacity constraints, and incremental demand may not fully convert into current-period shipments.
- There is execution risk in the investment pace for Intel 14A and 18A, progress in risk reduction, and the ramp to high-volume manufacturing in 2028.
- If Intel subsequently cuts or delays capital expenditure, the upside in ASML's and ASMI's orders and revenue may be lower than expected.
- The report includes disclosures regarding Morgan Stanley's investment banking business and shareholdings with certain covered companies, and investors should be aware of potential conflicts of interest.
- The document does not provide a new target price or valuation sensitivity, and the event impact is reflected more as a directional judgment.
What to watch
- Whether Intel's subsequent capital expenditure guidance continues to remain above 2026 levels.
- Tool orders, risk reduction, and mass production timelines for Intel 14A, 18A, and 18A-P nodes.
- ASML's actual shipment volume of low-NA EUV tools to Intel, especially whether 2026 approaches the demand range of 2 to 4 units.
- Whether ASML further demonstrates pricing power and near-term margin improvement.
- Changes in ASMI's order disclosures and revenue contribution from Intel and advanced front-end tools.